FGFR3 and breast cancer: R3Mab (MFGR1877S) is a recombinant human antibody designed to selectively bind to the IgII and IgIII domains of FGFR3 shown to exhibit anti-tumor activity in in vitro studies, in BC models and in mouse xenograft models [81].